3M, an American conglomerate operating in industry, worker safety, healthcare, and consumer goods, announced the appointment of Bryan Hanson as chief executive officer of its new healthcare business.
On Tuesday, Aug. 22, it said that the newly-appointed executive will lead the healthcare group that it plans to spinoff. Last year, 3M shared its plans to create a new branch for its healthcare line.
There are plans to turn this health business into a listed company where 3M will keep its 19.9% stake. The firm is looking to complete the spinoff before this year ends. As per Reuters, the plan is to direct the focus of this healthcare unit to oral care, wound care, and healthcare technology, accounting for around 25% of the company's $34.43 billion in sales in 2022.
In any case, Hanson will officially join 3M on Sept. 1 and immediately assume the role of CEO of the firm's Health Care Business Group. Before this appointment, he worked as president and chief at Zimmer Biomet since 2017. He was promoted to the chairman post in 2021, and now he has left the Indiana-based medical equipment manufacturer to move to 3M.
Aside from hiring a new CEO, 3M also revealed that Carrie Cox, the former chairman and CEO of Humacyte Inc., will also be the chairman of the board of directors for the healthcare spinoff.
"We are pleased to have Bryan join us to successfully complete the spinoff of our Health Care business and build a leading independent medical technology innovation company," 3 M's chairman and chief executive officer, Mike Roman, said in a press release. "His industry expertise, ability to drive growth, and track record of building a strong culture and teams will make an immediate impact."
Photo by: visuals/Unsplash


US Launches New Iran Strikes as Strait of Hormuz Conflict Escalates, Oil Prices Rise
Zhipu AI Raises HK$31.37 Billion in Discounted Share Sale to Accelerate AI Growth
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
Gold Price Climbs Over 1% as Dollar Weakens, Fed Rate Debate and Iran Tensions Remain in Focus
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Fed Reaffirms 2% Inflation Goal, Vows Forceful Action to Anchor Price Expectations
Japanese Yen Rises as Pension Fund Plan and BOJ Rate Hike Bets Weigh on Dollar
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Asian Stocks Slip as Iran Tensions, Samsung Weakness and Fed Caution Weigh on Markets
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
Fed Chair Kevin Warsh Launches Task Forces to Overhaul U.S. Monetary Policy Framework 



